Background and Aim: The use of dermoscopy in nail diseases is quite recent. Dermoscopy allows a better visualisation of abnormalities of the nail bed and matrix in case of atypical clinical features in psoriatic nail. Th...
Anaplastic large-cell lymphoma (ALCL) is a CD30-positive non-Hodgkin lymphoma of T-cell origin. It comprises approximately 3% of all non- Hodgkin lymphomas. The skin may be the primary involvement site (primary cutaneous...
Background and Design: Pernio is an inflammatory disease that occurs in the acral regions of the body after exposure to cold. The study aimed to investigate the demographic findings of patients diagnosed with pernio and...
Ustekinumab is a Food and Drug Administration-approved (2009) novel treatment for psoriasis patients. This anti-interleukin-12/23p40 monoclonal antibody is effective in the treatment of plaque psoriasis and psoriatic art...
Dermoscopic findings of psoriatic nail and their relationship with disease severity
Background and Aim: The use of dermoscopy in nail diseases is quite recent. Dermoscopy allows a better visualisation of abnormalities of the nail bed and matrix in case of atypical clinical features in psoriatic nail. Th...
Fatal anaplastic lymphoma kinase positive anaplastic large cell lymphoma presenting with cutaneous lesions: A case report
Anaplastic large-cell lymphoma (ALCL) is a CD30-positive non-Hodgkin lymphoma of T-cell origin. It comprises approximately 3% of all non- Hodgkin lymphomas. The skin may be the primary involvement site (primary cutaneous...
Demographic findings of patients diagnosed with pernio and comparison of their vitamin B12, folate and ferritin levels with a control group
Background and Design: Pernio is an inflammatory disease that occurs in the acral regions of the body after exposure to cold. The study aimed to investigate the demographic findings of patients diagnosed with pernio and...
Ustekinumab associated bullous pemphigoid in a psoriasis patient and a review of the literature
Ustekinumab is a Food and Drug Administration-approved (2009) novel treatment for psoriasis patients. This anti-interleukin-12/23p40 monoclonal antibody is effective in the treatment of plaque psoriasis and psoriatic art...
A case of linear syringocystadenoma papilliferum of the axilla: A rare location
.